QMAC dRAST™
– SIMPLIFY YOUR AST WORKFLOW

dRAST™ is a rapid AST platform that identifies optimal antimicrobial after a positive blood culture, while other conventional systems take 2-3 days

Fast AST in less than 7 hours from positive blood culture

Up to 19 different antibiotics in several concentrations in one run

Use the right antibiotic sooner and reduce amount of broad spectrum

Let dRASTTM handle your AST workflow while you are doing something else

EXPERIENCE THE POWER OF dRAST’S RANDOM ACCESS CAPABILITY AND IMPROVE YOUR LABORATORY TURN-AROUND TIME

FAST

Rapid AST with
MIC & SIR direct from PBC

COMPREHENSIVE

Full Expert System on board
with dynamic algorithm

EASY

Easy to use interface
with low hands-on time

RANDOM ACCESS

Continuous loading for optimal handling of urgent care patients

FLEXIBLE

Incorporationg international guidelines & recommendations: EUCAST, CLSI & CA-SFM

CONNECTED

LIS BI-directional with easy Bacteria
Identification integration

Patended 96 Wells Plate with Dried Antibiotics

Feature

Gram Positive / Gram Negative panels for positive blood culture

Reporting Susceptibility by Prorietary Algoritm and Database

Feature

Automated image processing for growth measurement.S I R(Susceptible, Intermediate and Resistant) determination based on database and expert rules in collaboration with EUCAST.

Less Loading more Efficiency

No Sub-Culture

By eliminating requirement for sub-cultures, dRAST™ improves your lab efficiency by reducing TAT for Antibiotic Susceptibility testing

No McFarland

dRAST™ system does not require turbidity measurements

dRAST™ is the solution to help you care for Sepsis patients

Frequently Asked Questons

Gram Negative

on dRASTTM GN panel, we feature 4 drug mixes:

-Cefotaxime

-Cefotaxime / Clavulanic acid

-Ceftazidime

-Ceftazidime / Clavulanic acid

Based on CLSI decision matrix, dRASTTM will analyze the difference of MIC within these 4 drug mixes.

dRASTTM will therefore produce an ESBL result : Negative or Positive based on MIC differences

With 8 wells on Imipenem and 8 wells on Meropenem, we have a very clear MIC result which clearly indicates if the bacteria is resistant or not to carbapenem drugs. This also applies to Pseudomonas aeruginosa and Acinetobacter baumannii

dRASTTM does not feature an AmpC flag per se but with the 3 cephalosporin drugs present on GN panel (Cefepime, Cefotaxime, Ceftazidime), dRASTTM provides a clear susceptibility information regarding any resistance towards cephalosporin drugs.

Gram Positive

For Staphylococcus aureusStaphylococcus lugdunensis Staphylococcus saprophyticus, we feature Oxacillin and Cefoxitin Screen which clearly indicates the difference between MRSA & MSSA.For other Staphylococcus species, resistance is determined on Oxacillin MIC results. Cefoxitin Screen is less susceptible for these species.

Yes. If the strain is resistant to Erythromycin, in this case, dRASTTM considers the iCLI well on GP panel (mix of Erythromycin/Clindamycin). If any growth on iCLI well, iCLI appears positive and resistance to Clindamycin is detected

With 7 wells on Vancomycin, MIC result is produced on Vancomycin providing clear indication of VRE.

With 7 wells on Teicoplanin and 7 wells on Vancomycin, MIC result is produced on dRASTTM providing clear indication of GISA presence.

Other interesting content

Looking for something else? You might be interested in this as well.

Culture Media

SSI Diagnostica holds many years of experience within production of culture media. Our production facilities are modern with high capacity and ISO 13485 certified.

Read more

Rapid Tests – Fast and easy aid in the diagnosis

Rapid tests are lateral flow immunoassays for qualitative detection.

Read more

Contact

Please, reach out if you have questions, comments or requests.